# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Brian Morton maintains Bank of Nova Scotia (TSX:BNS) with a Equal-Weight and raises the price target from C...
https://www.bloomberg.com/news/articles/2025-08-27/scotiabank-gets-2-7-million-from-dallas-to-open-regional-hub?srnd=homepage-a...
RBC Capital analyst Darko Mihelic maintains Bank of Nova Scotia (NYSE:BNS) with a Sector Perform and raises the price target...
Bank of Nova Scotia (NYSE:BNS) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.2...
Following the announcement of TNF inhibitor, INmune Bio Inc. stock surged by 24.72% in after-hours trading on Friday.